Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Hampp

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Diabetes Care|July 11, 2020
Erratum. Use of Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Type 1 Diabetes and Rates of Diabetic Ketoacidosis. Diabetes Care 2020;43:90-97Christian Hampp, Richard S Swain, Casie Horgan, et al.
Diabetes Care|October 12, 2019
Use of Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Type 1 Diabetes and Rates of Diabetic KetoacidosisChristian Hampp, Richard S Swain, Casie Horgan, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 23, 2025
Ranking the Importance of Prognostic Factors for Relapsed/Refractory Multiple Myeloma: International Physician Panel Consensus Following a Systematic Literature ReviewShaji Kumar, Xavier Leleu, Katja C Weisel, et al.
Diabetes Care|November 11, 2017
Prospective Postmarketing Surveillance of Acute Myocardial Infarction in New Users of Saxagliptin: A Population-Based StudySengwee Toh, Marsha E Reichman, David J Graham, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 12, 2026
Second Primary Malignancy Risk in Patients with Multiple Myeloma Receiving CAR T-Cell Therapy or Other Systemic Anticancer Treatments: A Real-World Comparative StudyAttaya Suvannasankha, Mengying Li, Omonefe Omofuma, et al.
Pharmacoepidemiology and Drug Safety|November 19, 2019
Data linkage in pharmacoepidemiology: A call for rigorous evaluation and reportingNicole L Pratt, Christina D Mack, Anne Marie Meyer, et al.
Pharmaceutical Medicine|January 15, 2020
Evaluation of the US Food and Drug Administration Sentinel Analysis Tools Using a Comparator with a Different Indication: Comparing the Rates of Gastrointestinal Bleeding in Warfarin and Statin UsersRyan M Carnahan, Joshua J Gagne, Christian Hampp, et al.
Annals of Internal Medicine|April 26, 2016
Risk for Hospitalized Heart Failure Among New Users of Saxagliptin, Sitagliptin, and Other Antihyperglycemic Drugs: A Retrospective Cohort StudySengwee Toh, Christian Hampp, Marsha E Reichman, et al.
Epidemiology (Cambridge, Mass.)|July 7, 2017
Sentinel Modular Program for Propensity Score-Matched Cohort Analyses: Application to Glyburide, Glipizide, and Serious HypoglycemiaMeijia Zhou, Shirley V Wang, Charles E Leonard, et al.
European Journal of Haematology|May 9, 2025
Prognostic Factors and Effect Modifiers in Patients With Relapse or Refractory Diffuse Large B-Cell Lymphoma After Two Lines of Therapy: A Systematic Literature and Expert Clinical ReviewBastian von Tresckow, Pau Abrisqueta, Irene Zamanillo, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Diabetes Care|July 11, 2020
Erratum. Use of Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Type 1 Diabetes and Rates of Diabetic Ketoacidosis. Diabetes Care 2020;43:90-97Christian Hampp, Richard S Swain, Casie Horgan, et al.
Diabetes Care|October 12, 2019
Use of Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Type 1 Diabetes and Rates of Diabetic KetoacidosisChristian Hampp, Richard S Swain, Casie Horgan, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 23, 2025
Ranking the Importance of Prognostic Factors for Relapsed/Refractory Multiple Myeloma: International Physician Panel Consensus Following a Systematic Literature ReviewShaji Kumar, Xavier Leleu, Katja C Weisel, et al.
Diabetes Care|November 11, 2017
Prospective Postmarketing Surveillance of Acute Myocardial Infarction in New Users of Saxagliptin: A Population-Based StudySengwee Toh, Marsha E Reichman, David J Graham, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 12, 2026
Second Primary Malignancy Risk in Patients with Multiple Myeloma Receiving CAR T-Cell Therapy or Other Systemic Anticancer Treatments: A Real-World Comparative StudyAttaya Suvannasankha, Mengying Li, Omonefe Omofuma, et al.
Pharmacoepidemiology and Drug Safety|November 19, 2019
Data linkage in pharmacoepidemiology: A call for rigorous evaluation and reportingNicole L Pratt, Christina D Mack, Anne Marie Meyer, et al.
Pharmaceutical Medicine|January 15, 2020
Evaluation of the US Food and Drug Administration Sentinel Analysis Tools Using a Comparator with a Different Indication: Comparing the Rates of Gastrointestinal Bleeding in Warfarin and Statin UsersRyan M Carnahan, Joshua J Gagne, Christian Hampp, et al.
Annals of Internal Medicine|April 26, 2016
Risk for Hospitalized Heart Failure Among New Users of Saxagliptin, Sitagliptin, and Other Antihyperglycemic Drugs: A Retrospective Cohort StudySengwee Toh, Christian Hampp, Marsha E Reichman, et al.
Epidemiology (Cambridge, Mass.)|July 7, 2017
Sentinel Modular Program for Propensity Score-Matched Cohort Analyses: Application to Glyburide, Glipizide, and Serious HypoglycemiaMeijia Zhou, Shirley V Wang, Charles E Leonard, et al.
European Journal of Haematology|May 9, 2025
Prognostic Factors and Effect Modifiers in Patients With Relapse or Refractory Diffuse Large B-Cell Lymphoma After Two Lines of Therapy: A Systematic Literature and Expert Clinical ReviewBastian von Tresckow, Pau Abrisqueta, Irene Zamanillo, et al.
Pageof 6